Literature DB >> 17428295

Influence of subject eligibility criteria on compliance with National Institutes of Health guidelines for inclusion of women, minorities, and children in treatment research.

Keith Humphreys1, Kenneth R Weingardt, Alex H S Harris.   

Abstract

BACKGROUND: Many alcohol treatment outcome studies exclude some patients with particular problems, such as psychiatric disorders, noncompliance, and homelessness. Such criteria may increase the likelihood of a study being successfully conducted, but may also have the unintended consequence of reducing a study's ability to comply with National Institutes of Health guidelines for inclusion of racial minorities, women, and children in treatment research. METHODS AND
RESULTS: This paper examined this issue empirically using 5 prior studies of treatment systems enrolling over 100,000 alcohol patients. Widely used eligibility criteria in the alcohol treatment field typically exclude between one-fifth to one-third of patients from enrolling in research. Under several eligibility criteria, most notably those for drug use and social/residential instability, women and African-American patients are substantially more likely to be excluded than are men and non-African-American patients, respectively.
CONCLUSIONS: In designing treatment studies with many eligibility criteria, researchers may therefore inadvertently be thwarting their own good faith efforts to ensure that a range of vulnerable populations are able to participate in research. We analyze the implications of this dilemma for the generalizability of treatment results and for research design, and provide data that may help researchers working in different treatment systems estimate the impact of various eligibility criteria.

Entities:  

Mesh:

Year:  2007        PMID: 17428295     DOI: 10.1111/j.1530-0277.2007.00391.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  18 in total

1.  Generalizability of clinical trials for cannabis dependence to community samples.

Authors:  Mayumi Okuda; Deborah S Hasin; Mark Olfson; Sharaf S Khan; Edward V Nunes; Ivan Montoya; Shang-Min Liu; Bridget F Grant; Carlos Blanco
Journal:  Drug Alcohol Depend       Date:  2010-05-26       Impact factor: 4.492

2.  A comparison of African-American versus Caucasian men screened for an alcohol administration laboratory study: recruitment and representation implications.

Authors:  Nora E Noel; Stephen A Maisto; Richard L Ogle; James D Johnson; Lee A Jackson; Calvin M Sims
Journal:  Addict Behav       Date:  2011-01-13       Impact factor: 3.913

3.  Representativeness of patients enrolled in influential clinical trials: a comparison of substance dependence with other medical disorders.

Authors:  Keith Humphreys; Natalya C Maisel; Janet C Blodgett; John W Finney
Journal:  J Stud Alcohol Drugs       Date:  2013-11       Impact factor: 2.582

4.  Generalizability of findings from randomized controlled trials: application to the National Institute of Drug Abuse Clinical Trials Network.

Authors:  Ryoko Susukida; Rosa M Crum; Cyrus Ebnesajjad; Elizabeth A Stuart; Ramin Mojtabai
Journal:  Addiction       Date:  2017-03-16       Impact factor: 6.526

5.  Subject eligibility criteria can substantially influence the results of alcohol-treatment outcome research.

Authors:  Keith Humphreys; Alex H S Harris; Kenneth R Weingardt
Journal:  J Stud Alcohol Drugs       Date:  2008-09       Impact factor: 2.582

6.  Harnessing Implementation Science to Increase the Impact of Health Equity Research.

Authors:  Matthew Chinman; Eva N Woodward; Geoffrey M Curran; Leslie R M Hausmann
Journal:  Med Care       Date:  2017-09       Impact factor: 2.983

7.  Generalizing Treatment Effect Estimates From Sample to Population: A Case Study in the Difficulties of Finding Sufficient Data.

Authors:  Elizabeth A Stuart; Anna Rhodes
Journal:  Eval Rev       Date:  2016-08-04

8.  Generalizability of clinical trials for alcohol dependence to community samples.

Authors:  Carlos Blanco; Mark Olfson; Mayumi Okuda; Edward V Nunes; Shang-Min Liu; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2008-06-24       Impact factor: 4.492

9.  Venue-based recruitment of women at elevated risk for HIV: an HIV Prevention Trials Network study.

Authors:  Danielle F Haley; Carol Golin; Wafaa El-Sadr; James P Hughes; Jing Wang; Malika Roman Isler; Sharon Mannheimer; Irene Kuo; Jonathan Lucas; Elizabeth DiNenno; Jessica Justman; Paula M Frew; Lynda Emel; Anne Rompalo; Sarah Polk; Adaora A Adimora; Lorenna Rodriquez; Lydia Soto-Torres; Sally Hodder
Journal:  J Womens Health (Larchmt)       Date:  2014-04-17       Impact factor: 2.681

10.  Combination therapy of molecular hydrogen and hyperoxia improves survival rate and organ damage in a zymosan-induced generalized inflammation model.

Authors:  Yunchuan Hong; L I Sun; Ruiqiang Sun; Hongguang Chen; Yonghao Yu; Keliang Xie
Journal:  Exp Ther Med       Date:  2016-04-06       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.